Impaired cell-mediated immunity in experimental abdominal sepsis and the effect of interleukin 2
- PMID: 1524487
- DOI: 10.1001/archsurg.1992.01420070123022
Impaired cell-mediated immunity in experimental abdominal sepsis and the effect of interleukin 2
Abstract
A murine model of experimental sepsis, ie, cecal ligation and puncture, was used to determine the potential effects of infection on in vitro cell-mediated immunity. Following cecal ligation and puncture, in vitro responses of mouse splenocytes to mitogens (phytohemagglutinin and concanavalin A), the effects of in vitro interleukin 2 on these responses, and the impact of in vivo interleukin 2 on survival were studied. Compared with controls (sham cecal ligation and puncture), phytohemagglutinin responses 1 day after cecal ligation and puncture were enhanced (43% +/- 17%, n = 9), phytohemagglutinin and concanavalin A responses at day 4 were suppressed (45.5% +/- 4.4% and 57.5% +/- 5.6%), and, by day 7, phytohemagglutinin and concanavalin A responses were approaching values in mice treated by sham cecal ligation and puncture. Suppressed phytohemagglutinin responses at day 4 after cecal ligation and puncture were restored to normal with in vitro interleukin 2 (61,052 +/- 3407 cpm for cecal ligation and puncture and 64,643 +/- 4727 cpm for sham cecal ligation and puncture). Mortalities following cecal ligation and puncture were identical at day 1 after cecal ligation and puncture (6/20) for both interleukin 2- and vehicle-treated groups; thereafter, interleukin 2-treated groups fared better. At day 1 after cecal ligation and puncture, the mean spleen cell phytohemagglutinin response was enhanced (43.8% +/- 17%, n = 9) compared with sham cecal ligation and puncture (= 10). By day 4, the responses to both concanavalin A and phytohemagglutinin were suppressed (45.5% +/- 4.4% and 57.5% +/- 5.6%, respectively). Responses at day 7 approached those of controls given sham cecal ligation and puncture. Sepsis causing a temporary impairment of cell-mediated immunity may be a factor in the frequent coexistence of altered cell-mediated immunity and sepsis, and interleukin 2 may have a role in limiting the adverse effects of sepsis.
Similar articles
-
Enhancement of peritoneal leukocyte function by granulocyte colony-stimulating factor in rats with abdominal sepsis.Crit Care Med. 1998 Feb;26(2):315-21. doi: 10.1097/00003246-199802000-00035. Crit Care Med. 1998. PMID: 9468171
-
Delayed Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Inhibition by Trametinib Attenuates Systemic Inflammatory Responses and Multiple Organ Injury in Murine Sepsis.Crit Care Med. 2016 Aug;44(8):e711-20. doi: 10.1097/CCM.0000000000001672. Crit Care Med. 2016. PMID: 27031380 Free PMC article.
-
Temporal correlation of impaired immune response after thermal injury with susceptibility to infection in a murine model.Surgery. 1988 Nov;104(5):882-7. Surgery. 1988. PMID: 3263707
-
Experimental Protocol for Cecal Ligation and Puncture Model of Polymicrobial Sepsis and Assessment of Vascular Functions in Mice.Methods Mol Biol. 2018;1717:161-187. doi: 10.1007/978-1-4939-7526-6_14. Methods Mol Biol. 2018. PMID: 29468592 Review.
-
The Effects of Obesity on Outcome in Preclinical Animal Models of Infection and Sepsis: A Systematic Review and Meta-Analysis.J Obes. 2020 Feb 17;2020:1508764. doi: 10.1155/2020/1508764. eCollection 2020. J Obes. 2020. PMID: 32211204 Free PMC article.
Cited by
-
Pretreatment with enteral cholestyramine prevents suppression of the cellular immune system after partial hepatectomy.Ann Surg. 1995 Mar;221(3):282-90. doi: 10.1097/00000658-199503000-00011. Ann Surg. 1995. PMID: 7717782 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases